Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

NCT: NCT07246993 · RECRUITING

NCT IDNCT07246993
StatusRECRUITING
Start Date2026-03-05
Completion2028-01-01
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).

Frequently Asked Questions

What is Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms?

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms is a clinical trial registered under NCT07246993. Current status: RECRUITING.

What is the status of NCT07246993?

The current status of NCT07246993 (Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms) is: RECRUITING.

When did Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms start?

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms started on 2026-03-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.